Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer
Xuewen Liu et al, 2018, International Journal of Oncology CrossRef
Brevilin A Induces Cell Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma
Rui Liu et al, 2019, Frontiers in Pharmacology CrossRef
Multiple Myeloma Inhibitory Activity of Plant Natural Products
Karin Jöhrer et al, 2021, Cancers CrossRef
Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Xuewen Liu et al, 2017, Signal Transduction and Targeted Therapy CrossRef
Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A
Lan Jin et al, 2018, International Journal of Oncology CrossRef
Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer
Juanli Ji et al, 2018, Cancer Biomarkers CrossRef
Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme
Shanshan Qin et al, 2018, Molecular Carcinogenesis CrossRef
Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A
Qiuyue Huang et al, 2017, Oncology Reports CrossRef
Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae)
Serhat Sezai Ҫiҫek et al, 2021, RSC Advances CrossRef
Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/Adriamycin cells
Fen Cai et al, 2016, Oncology Reports CrossRef
Pharmacological Activities of Brevilin A: A Mini-Review
Heng Yang et al, 2024, Current Pharmacology Reports CrossRef
Arnicolide D, from the herb Centipeda minima, Is a Therapeutic Candidate against Nasopharyngeal Carcinoma
Rui Liu et al, 2019, Molecules CrossRef
Unraveling the Anticancer Components of Centipeda minima and their Cellular Targets in Human Cancers
Muhammad Faisal Maqbool et al, 2022, Journal of Biologically Active Products from Nature CrossRef